Indeed hopefully we can push beyond 3 or 4 cents soon. Odd to think that the options which expired last year were 44 cents! The revenue attached to this company far outweighs nearly every stock of a similar market cap.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025